News
HC Wainwright & Co. Reiterates Buy on Corcept Therapeutics, Maintains $38 Price Target
23 Apr 24
News, Price Target, Reiteration, Analyst Ratings
What's Going On With Stress Hormone Modulator-Focused Corcept Therapeutics' Stock Friday?
16 Feb 24
Biotech, News, Guidance, Health Care, Movers, General
Corcept Announces Preliminary Results From Prevalence Phase Of CATALYST Clinical Trial; Of The First 700 Patients Enrolled In Catalyst, 24% Were Identified As Having Hypercortisolism
15 Feb 24
Biotech, News, General
Earnings Scheduled For February 15, 2024
15 Feb 24
Earnings
Earnings Preview: Corcept Therapeutics
14 Feb 24
Earnings